Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
4 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Dynamic nature of BRAF or KRAS p.G12C mutations in second-line therapy for advanced colorectal cancer patients: do early and late effects exist?
Br J Cancer. 2024 Mar;130(5):777-787. doi: 10.1038/s41416-023-02563-w. Epub 2024 Jan 8.
Br J Cancer. 2024.
PMID: 38191609
Potential treatment strategy for the rare osimertinib resistant mutation EGFR L718Q.
Song Y, Jia Z, Wang Y, Wang Y, Liu P, Zhang S, Bing Z, Cao L, Cao Z, Rossi E, Zamarchi R, Denis MG, Camps C, Fernandez-Diaz AB, Liang N, Li S.
Song Y, et al. Among authors: fernandez diaz ab.
J Thorac Dis. 2020 May;12(5):2771-2780. doi: 10.21037/jtd.2020.03.29.
J Thorac Dis. 2020.
PMID: 32642185
Free PMC article.
Item in Clipboard
Are patients in haemodialysis good candidates for immunotherapy treatment?
Fernandez-Diaz AB, Cunquero-Tomas AJ, Garcia-Medina A, Ferrer-Guillen B, Berrocal A.
Fernandez-Diaz AB, et al.
Melanoma Res. 2019 Oct;29(5):553-555. doi: 10.1097/CMR.0000000000000616.
Melanoma Res. 2019.
PMID: 31464825
Item in Clipboard
Eye immune privilege? Nivolumab plus ipilimumab: successful treatment in a patient with cutaneous melanoma and ocular metastases.
Fernandez-Diaz AB, García-Medina A, Ferrer-Guillen B, Berrocal A.
Fernandez-Diaz AB, et al.
Melanoma Res. 2019 Jun;29(3):345-347. doi: 10.1097/CMR.0000000000000591.
Melanoma Res. 2019.
PMID: 31022059
No abstract available.
Item in Clipboard
Cite
Cite